section name header

Information

[Section Outline]

Microbiology and Pathogenesis !!navigator!!

The herpes simplex viruses HSV-1 and HSV-2 are linear, double-stranded DNA viruses that share 50% sequence homology. Exposure to HSV at mucosal surfaces or abraded skin sites permits viral entry and replication in cells of the epidermis and dermis prior to infection of neuronal cells and development of a latent infection in ganglia.

  • Reactivation occurs when normal viral gene expression resumes, with reappearance of the virus on mucosal surfaces.
  • Both antibody-mediated and cell-mediated immunity (including type-specific immunity) are clinically important.

Epidemiology !!navigator!!

HSV-1 is acquired more frequently and at an earlier age than HSV-2. More than 90% of adults have antibodies to HSV-1 by the fifth decade of life. Antibodies to HSV-2 usually are not detected until adolescence and correlate with sexual activity. The seroprevalence of HSV-2 is higher in the developing than in the developed world; up to 60% of pregnant women in sub-Saharan Africa are seropositive.

  • HSV is transmitted by contact with active lesions or with virus shed from mucocutaneous surfaces by asymptomatic persons.
  • HSV reactivation is very common: HSV DNA can be detected on 20-30% of days by PCR, with most genital reactivation episodes lasting <6 h.
  • The large reservoir of unidentified carriers and the frequent asymptomatic reactivation of HSV-2 have fostered the continued spread of HSV throughout the world.
  • HSV-2 infection is associated with a two- to fourfold increase in HIV-1 acquisition; in fact, 33-50% of HIV-1 infections may be attributable to HSV-2 in men who have sex with men and in populations of sub-Saharan Africa.

Clinical Manifestations !!navigator!!

Both viral subtypes can cause indistinguishable genital and oral-facial infections. Overall, genital HSV-2 is twice as likely to reactivate as genital HSV-1, and HSV-2 infection recurs 8-10 times more often. In contrast, oral-labial HSV-1 infection recurs more frequently than oral-labial HSV-2 infection. The incubation period for primary infection with either virus is 1-26 days (median, 6-8 days).

Oral-Facial Infections !!navigator!!

Primary HSV-1 infection results in gingivostomatitis, pharyngitis, and up to 2 weeks of fever, malaise, myalgia, inability to eat, and cervical adenopathy, with lesions on the palate, gingiva, tongue, lip, face, posterior pharynx, and/or tonsillar pillars and occasional exudative pharyngitis.

  • Reactivation of HSV from the trigeminal ganglia is associated with asymptomatic viral excretion in the saliva, intraoral mucosal ulcerations, or ulcers on the vermilion border of the lip or external facial skin.
    • Approximately 50-70% of pts undergoing trigeminal nerve-root decompression and 10-15% of pts undergoing dental extraction develop oral-labial herpes a median of 3 days after the procedure.
    • Reactivation of HSV-1 or VZV in the mandibular portion of the facial nerve causes flaccid paralysis (Bell's palsy).
  • Immunosuppressed pts can have a severe infection that extends into the mucosa and skin, causing friability, necrosis, bleeding, pain, and inability to eat or drink.
  • Pts with atopic dermatitis may also develop severe oral-facial HSV infection (eczema herpeticum), with extensive skin lesions and occasional visceral dissemination.
  • HSV infection is the precipitating event in 75% of cases of erythema multiforme.

Genital Infections !!navigator!!

First-episode primary genital herpes is characterized by fever, headache, malaise, and myalgias (see Chap. 86 Sexually Transmitted and Reproductive Tract Infections). Pain, itching, dysuria, vaginal and urethral discharge, and tender inguinal lymphadenopathy are the predominant local symptoms.

  • Pts with prior HSV-1 infection have milder cases.
  • Reactivation infections are often subclinical or can cause genital lesions or urethritis with dysuria.
  • Even without a history of rectal intercourse, perianal lesions can occur as a result of latency established in the sacral dermatome from prior genital tract infection.

Whitlow !!navigator!!

In HSV infection of the finger, pts experience an abrupt onset of edema, erythema, pain, and vesicular or pustular lesions of the fingertips that are often confused with the lesions of pyogenic bacterial infection. Fever, lymphadenitis, and epitrochlear and axillary lymphadenopathy are common.

Herpes Gladiatorum !!navigator!!

HSV infection caused by trauma to the skin during wrestling can occur anywhere on the body but commonly affects the thorax, ears, face, and hands.

Eye Infections !!navigator!!

HSV is the most frequent cause of corneal blindness in the United States.

  • HSV keratitis presents as acute onset of pain, blurred vision, chemosis, conjunctivitis, and dendritic corneal lesions. Topical glucocorticoids may exacerbate disease. Recurrences are common.
  • Other manifestations include chorioretinitis and acute necrotizing retinitis.

Central and Peripheral Nervous System Infections !!navigator!!

In the United States, HSV causes 10-20% of all cases of sporadic viral encephalitis, and 95% of these cases are due to HSV-1 (either primary or reactivated infection). The estimated annual incidence is 2.3 cases per 1 million persons.

  • Pts present with an acute onset of fever and focal neurologic symptoms and signs, especially in the temporal lobe. In severe cases, RBCs can be found in the CSF as a result of hemorrhagic necrosis.
  • Given the potential severity of infection, antiviral treatment should be started empirically until the diagnosis is confirmed or an alternative diagnosis is made.
  • HSV meningitis, which is usually seen in association with primary genital HSV infection, is an acute self-limited disease manifested by headache, fever, and mild photophobia and lasting 2-7 days.
    • Of cases of aseptic meningitis, 3-15% are due to HSV.
    • HSV is the most common cause of recurrent lymphocytic meningitis (Mollaret's meningitis).
  • Autonomic dysfunction caused by either HSV or VZV most commonly affects the sacral region, resulting in numbness, tingling of the buttocks or perineal areas, urinary retention, constipation, and impotence.
    • Symptoms take days or weeks to resolve.
    • In rare instances, transverse myelitis or Guillain-Barré syndrome follows HSV infection.

Visceral Infections !!navigator!!

HSV infection of visceral organs usually results from viremia; multiple-organ involvement is common, but occasionally only the esophagus, lung, or liver is affected.

  • In HSV esophagitis, pts present with odynophagia, dysphagia, substernal pain, weight loss, and multiple oval ulcerations on an erythematous base. Detection of HSV is necessary to distinguish this entity from esophagitis of other etiologies (e.g., Candida esophagitis).
  • HSV pneumonitis is rare except among severely immunocompromised pts and results in focal necrotizing pneumonitis with a mortality rate of >80%.
  • Hepatic HSV infection occurs primarily in immunocompromised pts and is associated with fever, abrupt elevations of bilirubin and serum aminotransferase levels, and leukopenia (<4000 WBCs/µL).

Neonatal Infections !!navigator!!

The frequency of visceral and/or CNS infection is highest among HSV-infected infants <6 weeks of age; the mortality rate without therapy is 65%.

  • Infection is usually acquired perinatally from contact with infected genital secretions during delivery.
  • Approximately 50-70% of cases are due to HSV-2. The risk is elevated 10-fold for infants born to a mother who has recently acquired HSV.

Diagnosis !!navigator!!

PCR is the recommended test for diagnosing HSV. Microscopic evaluation, viral culture (if antiviral sensitivity testing is needed), and serology are also clinically useful for diagnosing HSV infection, but these tests have lower sensitivities.

  • Regardless of the detection method, the sensitivity is greater for vesicular rather than ulcerative mucosal lesions, in primary rather than recurrent disease, and in immunocompromised rather than immunocompetent pts.
  • A Tzanck smear (Giemsa-stained scrapings from the base of lesions) to detect giant cells or intranuclear inclusions characteristic of both HSV and VZV infections has a low level of sensitivity; its use requires clinicians skilled in this technique.
  • Serologic tests can be used to demonstrate prior exposure to HSV; no reliable IgM detection method for defining acute HSV infection is available.
TREATMENT

Infections with Herpes Simplex Viruses

  • Table 102-1 Antiviral Chemotherapy for Herpes Simplex Virus (HSV) Infection details antiviral chemotherapy for HSV infection.
    • All antiviral agents licensed for use against HSV inhibit the viral DNA polymerase.
    • Acyclovir can crystallize in the renal parenchyma, causing transient renal insufficiency; this drug should be given over the course of 1 h to a well-hydrated pt.
    • Acyclovir-resistant strains of HSV are rare but have been identified, primarily in immunocompromised pts. In general, these isolates are also resistant to valacyclovir and famciclovir, which have similar mechanisms of action.
    • Antiviral drugs neither eradicate latent infection nor affect recurrence after treatment is discontinued.

Prevention !!navigator!!

The use of barrier forms of contraception, especially condoms, decreases the likelihood of HSV transmission, particularly during asymptomatic viral excretion. Chronic daily therapy with valacyclovir can also be partially effective in reducing acquisition of HSV-2, particularly by susceptible women.

Outline

Section 7. Infectious Diseases